1170 related articles for article (PubMed ID: 1881400)
21. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
Ostensen ME; Thiele DL; Lipsky PE
J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
23. Impaired release of natural killer cytotoxic factor(s) by peripheral blood lymphocytes in patients with chronic LGL-proliferative disease.
Eliopoulos GD; Vaiopoulos G; Kyriakou D; Eliopoulos AG; Papadaki H; Katrinakis G; Alexandrakis M
Haematologica; 1993; 78(4):219-24. PubMed ID: 8294053
[TBL] [Abstract][Full Text] [Related]
24. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
25. Long-term killing of natural killer-resistant target cells by interferon-alpha-, interferon-gamma-, and interleukin-2-activated natural killer cells.
Sarzotti M; Klimpel GR; Baron S
Nat Immun Cell Growth Regul; 1989; 8(2):66-75. PubMed ID: 2503715
[TBL] [Abstract][Full Text] [Related]
26. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
27. Modulation of in vitro porcine natural killer cell activity by recombinant interleukin-1 alpha, interleukin-2 and interleukin-4.
Knoblock KF; Canning PC
Immunology; 1992 Jun; 76(2):299-304. PubMed ID: 1634252
[TBL] [Abstract][Full Text] [Related]
28. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
29. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
[TBL] [Abstract][Full Text] [Related]
30. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
[TBL] [Abstract][Full Text] [Related]
31. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
32. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
Farram E; Targan SR
J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
[TBL] [Abstract][Full Text] [Related]
33. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
34. Studies on natural killer cells in chronic myeloid leukemia patients in remission.
Dabholkar M; Tatake RJ; Advani S; Gangal SG
Neoplasma; 1990; 37(1):47-53. PubMed ID: 1690865
[TBL] [Abstract][Full Text] [Related]
35. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
[TBL] [Abstract][Full Text] [Related]
36. Generation of a lipid-like cytotoxin from human CD16+ natural killer cells.
Cosentino LM; Cathcart MK
Cancer Res; 1989 Dec; 49(23):6662-9. PubMed ID: 2531033
[TBL] [Abstract][Full Text] [Related]
37. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
[TBL] [Abstract][Full Text] [Related]
38. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
39. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
Lotzová E; Savary CA; Herberman RB
J Immunol; 1987 Apr; 138(8):2718-27. PubMed ID: 3494084
[TBL] [Abstract][Full Text] [Related]
40. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
Chehimi J; Valiante NM; D'Andrea A; Rengaraju M; Rosado Z; Kobayashi M; Perussia B; Wolf SF; Starr SE; Trinchieri G
Eur J Immunol; 1993 Aug; 23(8):1826-30. PubMed ID: 8102101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
